Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins

Endocrine
Massimo ScacchiFrancesco Cavagnini

Abstract

Previous evidence supports a role for growth hormone (GH)-insulin-like growth factor (IGF)-I deficiency in the pathophysiology of osteopenia/osteoporosis in adult thalassemia. Moreover, serum IGF-II has never been studied in this clinical condition. Thus, we elected to study the GH secretory status and the levels of circulating somatomedins, correlating these parameters with bone mineral density (BMD) and biochemical markers of bone turnover. A hundred and thirty-nine normal weight adult thalassemic patients (72 men and 67 women) were studied. Lumbar and femoral neck BMD were measured in 106/139 patients. Sixty-eight patients underwent growth hormone releasing hormone plus arginine testing. Measurement of baseline IGF-I and IGF-II was performed in all patients, while osteocalcin, C-terminal telopeptide of type I collagen (CTx), and urinary cross-linked N-telopeptides of type I collagen (NTx) were assayed in 95 of them. Femoral and lumbar osteoporosis/Z score below the expected range for age were documented in 61.3 and in 56.6 % of patients, respectively. Severe GH deficiency (GHD) was demonstrated in 27.9 % of cases, whereas IGF-I SDS was low in 86.3 %. No thalassemic patients displayed circulating levels of IGF-II below the re...Continue Reading

References

Mar 1, 1996·European Journal of Endocrinology·E GhigoF Camanni
Oct 1, 1996·Journal of Cellular Physiology·C E StewartP Rotwein
Jun 26, 1998·Calcified Tissue International·M IshibeJ E Puzas
Jan 5, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S BoonenD J Baylink
Dec 21, 2000·British Journal of Haematology·S PerrottaA Iolascon
Nov 22, 2001·Journal of Endocrinological Investigation·D Tiosano, Z Hochberg
Aug 7, 2002·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Cheryl A ConoverSundeep Khosla
Jun 5, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Shreyasee AminSundeep Khosla
Oct 6, 2004·British Journal of Haematology·Ersi Voskaridou, Evangelos Terpos
Nov 10, 2005·The Journal of Clinical Endocrinology and Metabolism·Robert D MurrayStephen M Shalet
Apr 7, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Gherardo MazziottiAndrea Giustina
Jan 16, 2007·Journal of Pediatric Endocrinology & Metabolism : JPEM·Loredana PratelliVincenzo De Sanctis
Jul 5, 2007·Clinical Endocrinology·Massimo ScacchiFrancesco Cavagnini
Oct 17, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·B Lawrence RiggsSundeep Khosla
Apr 26, 2008·Endocrine Reviews·Andrea GiustinaErnesto Canalis
Oct 9, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sivanandane SittadjodyNarasimhan Srinivasan
Feb 8, 2013·International Journal of Pediatric Endocrinology·Lisa Swartz ToporCatherine M Gordon
Apr 26, 2014·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Phillip WongFrances Milat

❮ Previous
Next ❯

Citations

Dec 10, 2017·Hematology·Antonio Piga
Nov 30, 2018·Physiological Research·I Zofkova, P Nemcikova
Sep 16, 2020·Archives of Osteoporosis·Pokpong PiriyakhuntornNipon Chattipakorn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.